# Mikael Svensson

> Mikael Svensson is Chief Executive Officer of SaNOtize Research and Development Corp., the Vancouver-based company commercializing nitric oxide as an antimicrobial platform, most recently through its NOWONDER consumer nasal cleanser. A chemical engineer by training with more than two decades in medical device and pharmaceutical commercialization, he previously led the global launch of INOmax inhaled nitric oxide therapy and worldwide expansion work on Restylane, Naftin, Mederma and VagiVital.

- **Role:** Chief Executive Officer at SaNOtize Research and Development Corp.
- **Organizations:** SaNOtize Research and Development Corp., NOWONDER, Akira Aesthetic AB, Mustang Industrial Design, Common Sense Marketing, Inc.
- **Education:** Chemical Engineering (4-year post-secondary academic study), Post-secondary chemical engineering program
- **Known for:** Launched INOmax in the United States and Europe, Scaled Restylane worldwide in the aesthetics category, Oversaw commercial growth of Naftin, Mederma and VagiVital

## Career timeline

- **prior** — Trained as a chemical engineer
- **prior** — Directed the launch of INOmax, an FDA-approved inhaled nitric oxide therapy for newborn hypoxic respiratory failure, across U.S. and European markets
- **prior** — Led worldwide expansion of Restylane in aesthetics
- **prior** — Oversaw the scaling of Naftin (dermatology), Mederma (topical OTC), and VagiVital
- **prior** — Held roles at Akira Aesthetic AB, Mustang Industrial Design, and Common Sense Marketing, Inc.
- **2025-09** — Joined SaNOtize Research and Development Corp. as Chief Executive Officer
- **2026-04** — Received FDA warning letter (MARCS-CMS 727784) regarding NOWONDER Nasal Cleanser marketing

## Achievements

- Launched INOmax in the United States and Europe
- Scaled Restylane worldwide in the aesthetics category
- Oversaw commercial growth of Naftin, Mederma and VagiVital
- Appointed CEO of SaNOtize Research and Development Corp. in September 2025

## Latest updates

- **2025-09** — Named Chief Executive Officer of SaNOtize.
- **2026-04** — Named as the recipient of an FDA warning letter to SaNOtize regarding NOWONDER Nasal Cleanser.

## Links

- Website: https://sanotize.com
- LinkedIn: https://www.linkedin.com/in/mikael-svensson-dfw/
- Twitter/X: https://twitter.com/SanotizeD

---

Profile page: https://yespress.io/mikael-svensson
Published by YesPress — https://yespress.io
Last updated: 2026-07-09